$10.07
-0.15 (-1.47%)
Open$10.21
Previous Close$10.22
Day High$10.21
Day Low$9.83
52W High$22.55
52W Low$9.69
Volume—
Avg Volume206.2K
Market Cap221.07M
P/E Ratio—
EPS$-3.01
SectorBiotechnology
Analyst Ratings
Buy
14 analysts
Price Target
+95.6% upside
Current
$10.07
$10.07
Target
$19.70
$19.70
$13.49
$19.70 avg
$20.36
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 141.53M | 4.38M | 103.26M |
| Net Income | 50.46M | -207,966,613 | -15,524,708 |
| Profit Margin | 35.7% | -5,013.7% | -15.0% |
| EBITDA | 40.06M | -245,260,567 | -22,220,211 |
| Free Cash Flow | — | — | -17,331,210 |
| Rev Growth | — | -43.9% | +11.8% |
| Debt/Equity | — | — | 0.46 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |